The DOI matches its Crossref record, with a small difference in title or year; 36 of the 36 references it cites were found in a registry or an index.
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione
Abstract
Background — Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent (<3 months) myocardial infarction. Methods and Results — In this study, 11 323 patients were randomly assigned to supplements of n-3 PUFAs, vitamin E (300 mg/d), both, or no treatment (control) on top of optimal pharmacological treatment and lifestyle advice. Intention-to-treat analysis adjusted for interaction between treatments was carried out. Early efficacy of n-3 PUFA treatment for total, cardiovascular, cardiac, coronary, and sudden death; nonfatal myocardial infarction; total coronary heart disease; and cerebrovascular events was assessed by right-censoring follow-up data 12 times from the first month after randomization up to 12 months. Survival curves for n-3 PUFA treatment diverged early after randomization, and total mortality was significantly lowered after 3 months of treatment (relative risk [RR] 0.59; 95% CI 0.36 to 0.97; P =0.037). The reduction in risk of sudden death was specifically relevant and statistically significant already at 4 months (RR 0.47; 95% CI 0.219 to 0.995; P =0.048). A similarly significant, although delayed, pattern after 6 to 8 months of treatment was observed for cardiovascular, cardiac, and coronary deaths. Conclusions — The early effect of low-dose (1 g/d) n-3 PUFAs on total mortality and sudden death supports the hypothesis of an antiarrhythmic effect of this drug. Such a result is consistent with the wealth of evidence coming from laboratory experiments on isolated myocytes, animal models, and epidemiological and clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“contemporary high-intensity statin formulations achieve greater low-density lipoprotein–lowering effects and cardiovascular endpoint reduction than were used during the first mixed EPA/DHA trials, such as GISSI-P.17,27,44”
From Effects of Eicosapentaenoic Acid vs Eicosapentaenoic/Docosahexaenoic Acids on Cardiovascular Mortality (2025) · cites this paper as [44]
Experimental — accuracy not yet measuredIn the citing paper
“Data from meta-analyses suggest that a reduction of calculated glomerular filtration rate (GFR) does not reflect any adverse effects on kidney function [315].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [315]
In the citing paper
“Results from other meta-analyses suggest reduced major CVD events in patients with high TGs and low HDL-C in fibrate-treated patients, but no decrease in CVD or total mortality [314-316].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [315]
In the citing paper
“A post hoc subgroup analysis revealed that this reduction in mortality and SCD was concentrated in the approximately 2000 patients with reduced left ventricular ejection fraction [67].”
From Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health (2022) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
The Inverse Relation between Fish Consumption and 20-Year Mortality from Coronary Heart Disease
Kromhout, D., Bosschieter, E. B., & Coulander, C. D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121901 · Cited by 2,177
(1999) · PubMed · Cited by 2,062
Self-citationn-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Fish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990
The Composition of Food Consumed by Greenland Eskimos
Bang, H. O., Dyerberg, J., & Hjørne, N. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08198.x · Cited by 950
Siscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920
Fish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902
Research works printed but not linked: 10
Cited by
Sorted by citations
Items 801–900 of 1,000
Prevention of Atherosclerotic Cardiovascular Disease
Daniels, S. R. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.082 · Cited by 11
Arakawa, K., Himeno, H., Kirigaya, J., Otomo, F., Matsushita, K., Nakahashi, H., Shimizu, S., Nitta, M., Yano, H., Endo, M., et al. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.03.009 · Cited by 10
Efectos antitrombóticos y antiinflamatorios de los ácidos grasos omega-3
López-Farré, A. J., & Macaya, C. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)74824-5 · Cited by 9
Is B Vitamins Deficiency Associated with Prevalence of Alzheimer's Disease in Cuban Elderly?
Domínguez, Y. L., Hernández, M., Matos, C. M., & Zhou, D. (2006) · Nutrition and Health · doi:10.1177/026010600601800202 · Cited by 10
Omega-3 fatty acids, acute coronary syndrome, and sudden death
Harris, W. S., & von Schacky, C. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0029-9 · Cited by 10
Fish oils – adjuvant therapy in chronic heart failure?
Witte, K. K., & Clark, A. L. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000136728.27524.f5 · Cited by 10
Morishita, T., Uzui, H., Ikeda, H., Amaya, N., Kaseno, K., Ishida, K., Fukuoka, Y., Lee, J., & Tada, H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.079 · Cited by 10
Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death
Goldberger, J. J., Weinberg, K. M., & Kadish, A. H. (2004) · Elsevier eBooks · doi:10.1016/b0-7216-0323-8/50106-8 · Cited by 10
Kim, J. H., Yin, T., Shinozaki, K., Lampe, J. W., & Becker, L. B. (2016) · Scientific Reports · doi:10.1038/srep36545 · Cited by 10
Shorter Telomere Length in Peripheral Blood Cells Associated With Migraine in Women
Ren, H., Collins, V., Fernandez, F., Quinlan, S., Griffiths, L. R., & Choo, K. H. A. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01693.x · Cited by 11
Omacor and Omega-3 Fatty Acids for Treatment of Coronary Artery Disease and the Pleiotropic Effects
Kar, S. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31822b5603 · Cited by 12
Xue, Q., Zhu, H., Ya, R., & Huang, H. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2401024 · Cited by 13
Syncope and Driving, Flying and Vocational Concerns
Sakaguchi, S., & Li, H. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.11.010 · Cited by 9
Marchioli, R., & Levantesi, G. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.041 · Cited by 9
Self-citationUpdate on the role of triglycerides as a risk factor for coronary heart disease
Miller, M. J., Cosgrove, B., & Havas, S. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0044-0 · Cited by 9
Ruiz-Núñez, B., van den Hurk, G. H. A. M., de Vries, J. H. M., Mariani, M. A., de Jongste, M. J. L., Dijck-Brouwer, J., & Muskiet, F. A. J. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000434 · Cited by 9
Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?
Orso, F., Fabbri, G., Maggioni, A. P., & Azienda Ospedaliero-Universitaria Careggi, S. O. G. M. A. C. (2015) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2015.4.3.163 · Cited by 9
Self-citationSchwenger, K. J. P., Arendt, B. M., Smieja, M., David, W. L., Smaill, F., & Allard, J. P. (2019) · Nutrients · doi:10.3390/nu11061292 · Cited by 9
Omega 3 Fatty Acids and Health: The Little We Know after All These Years
Visioli, F., & Agostoni, C. V. (2022) · Nutrients · doi:10.3390/nu14020239 · Cited by 9
Omega–3 Fatty Acids, Exercise, Physical Activity and Athletics
Simopoulos, A. P. (2008) · World review of nutrition and dietetics · doi:10.1159/000152920 · Cited by 9
Claudia, F. G., Marcelo, B., & Giselle, H. R. (2012) · 老年心脏病学杂志：英文版 · doi:10.3724/sp.j.1263.2011.12292 · Cited by 9
Lipid Management in the Geriatric Patient
Nair, A. P., & Darrow, B. J. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.003 · Cited by 9
Wild, S. H., & Byrne, C. D. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.1424-5.x · Cited by 9
Pabón, G. M., & Perdomo, M. D. P. B. (2005) · Revista de la Facultad de Medicina · Cited by 9
Second International Congress on Seafood Technology on Sustainable, Innovative and Healthy Seafood
Ryder, J. D., Ababouch, L. H., & Balaban, M. Ö. (2012) · Cited by 9
Muroya, T., Kawano, H., Koga, S., Ikeda, S., Yamamoto, F., Miwa, T., Kohno, Y., & Maemura, K. (2018) · International Heart Journal · doi:10.1536/ihj.17-459 · Cited by 9
Modifiable Risk Factors for Cardiovascular Disease in CKD Patients
Seibert, E., Kuhlmann, M. K., & Levin, N. W. (2005) · KARGER eBooks · doi:10.1159/000085647 · Cited by 9
Taha, A. Y., Ciobanu, F. A., Saxena, A., & Burnham, W. M. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.10.012 · Cited by 9
Long-chain n-3 fatty acids in lipid rafts: implications for anti-inflammatory effects
Garattini, S. K. (2007) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000289277.10675.e8 · Cited by 9
Covaciu, A., Benedek, T., Bobescu, E., Rus, H., Benza, V., Marceanu, L. G., Grigorescu, S., & Strempel, C. G. (2025) · Marine Drugs · doi:10.3390/md23040154 · Cited by 8
Effects of omega-3 polyunsaturated fatty acids on cardiac myocyte protection
Bei, R. (2010) · Frontiers in bioscience · doi:10.2741/3825 · Cited by 8
ω-3 polyunsaturated fatty acids and the cardiovascular system
Крыжановский, С. А., & Вититнова, М. Б. (2009) · Human Physiology · doi:10.1134/s036211970904015x · Cited by 10
Functional Lipids as Nutraceuticals: A Review
Bhat, S. S. (2021) · International Journal of Science and Healthcare Research · doi:10.52403/ijshr.20211018 · Cited by 8
Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease
Marchioli, R. (2010) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s4743 · Cited by 8
Self-citationHarris, W. S., Kennedy, K. F., Maddox, T. M., Kutty, S., & Spertus, J. A. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.11.006 · Cited by 8
DiNicolantonio, J. J., Meier, P., & O’Keefe, J. H. (2013) · Europe PMC (PubMed Central) · Cited by 8
Colussi, G., Catena, C., Fagotto, V., Darsiè, D., Brosolo, G., Bertin, N., & Sechi, L. A. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1434126 · Cited by 8
Lilleberg, H. S., Cichosz, S. L., Svensson, M., Christensen, J. H., Fleischer, J., Eide, I. A., & Jenssen, T. G. (2019) · Nutrients · doi:10.3390/nu11122847 · Cited by 8
Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease
O’Connell, T. D., Murphy, K. A., Zhang, N., Puccini, S. J., Healy, C. L., Harsch, B. A., Zhang, M. J., & Shearer, G. C. (2022) · Physiology · doi:10.1152/physiol.00007.2022 · Cited by 9
Assessing the Highest Level of Evidence from Randomized Controlled Trials in Omega-3 Research
Sahye‐Pudaruth, S., & David, W. L. (2023) · Nutrients · doi:10.3390/nu15041001 · Cited by 9
Omega-3 fatty acid supplementation for the prevention of arrhythmias
Chung, M. K. (2008) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-008-0031-z · Cited by 8
Xu, X., Jiang, M., Wang, Y., Smith, T. M., Baumgarten, C. M., Wood, M. A., & Tseng, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010140 · Cited by 8
Polyunsaturated Fatty Acids in Atrial Fibrillation: Looking for the Proper Candidates
Salvador, O., Gómez-Gallanti, A., Garófalo, D., Noujaim, S. F., Peinado, R., & Rama, D. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00370 · Cited by 8
Roberts, C. K. (2014) · CRC Press eBooks · doi:10.1201/b16783-5 · Cited by 8
Fish oil—an appetising alternative to anti-arrhythmic drugs?
Albert, C. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16135-7 · Cited by 8
Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death
Majmudar, M. D., TOMPKINS, C. M., Bachmann, J. M., Blumenthal, R. S., & Marine, J. E. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181861be8 · Cited by 8
Cardioprotection by omega-3 fatty acids: Involvement of PKCs?
Guennec, J. L., Jude, S., Besson, P., Martel, E., & Champéroux, P. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.02.024 · Cited by 8
den Ruijter, H. M., & Coronel, R. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6172-9 · Cited by 8
Unacknowledged Health Benefits of Genetically Modified Food: Salmon and Heart Disease DeathsPreprint
Lutter, R., & Tucker, K. L. (2002) · RePEc: Research Papers in Economics · Cited by 7
N-3 Fatty Acids for Hypertriglyceridemia in Patients Taking Second-Generation Antipsychotics
Fetter, J. C., Brunette, M., & Green, A. I. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.febr.012513 · Cited by 7
Herbal, Vitamin, and Mineral Supplement Use in Patients Enrolled in a Cardiac Rehabilitation Program
Nieva, R., Safavynia, S. A., Bishop, K., & Sperling, L. S. (2012) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0b013e31825f78f0 · Cited by 8
Tatsuno, I. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.971756 · Cited by 7
Schrover, I. M., Leiner, T., Klomp, D. W. J., Wijnen, J. P., Uiterwaal, C. S. P. M., Spiering, W., & Visseren, F. L. J. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24368 · Cited by 7
n-3 polyunsaturated fatty acids, lipids and lipoproteins in end-stage renal disease
Jeppe, H. C., Schmidt, E. B., & Svensson, M. (2011) · Clinical Lipidology · doi:10.2217/clp.11.50 · Cited by 7
Park, Y., & Kim, M. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511001930 · Cited by 7
The Use of Fish Oil Supplements in Clinical Practice: A Review
Guilliams, T. G. (2005) · Cited by 7
Moruf, R. O., AFOLAYAN, O. A., Taiwo, M. A., & Ogunbambo, M. M. (2021) · Croatian Journal of Food Science and Technology · doi:10.17508/cjfst.2021.13.1.13 · Cited by 7
Diet and Sudden Death: How to Reduce the Risk
Manolis, A. S., Manolis, T. A., Manolis, A. A., & Melita, H. (2022) · Current Vascular Pharmacology · doi:10.2174/1570161120666220621090343 · Cited by 7
Rosseel, Z., Cortoos, P., Jonckheer, J., Cools, W., Vinken, M., Reynaert, H., & Waele, E. D. (2023) · Nutrients · doi:10.3390/nu15112612 · Cited by 7
Bioactive Compounds in Heart Disease
Batchu, S. N., Chaudhary, K. R., Wiebe, G. J., & Seubert, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-396485-4.00026-8 · Cited by 7
n-3 Fatty acids and cardiovascular disease: the story is not over yet
Bilato, C. (2013) · Aging Clinical and Experimental Research · doi:10.1007/s40520-013-0077-y · Cited by 7
Insulin Resistance Syndrome and Glucose Dysregulation in the Elderly
Mazza, A. D. (2008) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2008.03.006 · Cited by 7
Cost Effectiveness of Complementary Medicines
Ernst, E. (2011) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2011.01080.x · Cited by 7
Standl, E. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112448876 · Cited by 7
Plasma fatty acid concentrations in Boxers and Doberman Pinschers
Smith, C. E., Freeman, L. M., Meurs, K. M., Rush, J. E., & Lamb, A. (2008) · American Journal of Veterinary Research · doi:10.2460/ajvr.69.2.195 · Cited by 7
Carpentier, Y., & Komsa‐Penkova, R. (2011) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2011.10.002 · Cited by 7
Optimal Dose of n-3 Polyunsaturated Fatty Acids for Cardiovascular Event Prevention
Nishizaki, Y., & Daida, H. (2020) · Circulation Reports · doi:10.1253/circrep.cr-20-0012 · Cited by 7
Effects of Omega‐3 Fatty Acids on Cardiovascular Disease: Summary
Wang, C., Chung, M. K., Lichtenstein, A. H., Balk, E. M., Kupelnick, B., DeVine, D., Lawrence, A., & Lau, J. T. F. (2004) · Cited by 7
Treatment of hypertriglyceridemia
Capell, W. H., & Eckel, R. H. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0040-9 · Cited by 7
Using Literature Based Discovery to Gain Insights Into the Metabolomic Processes of Cardiac Arrest
Henry, S., Wijesinghe, D. S., Myers, A., & McInnes, B. T. (2021) · Frontiers in Research Metrics and Analytics · doi:10.3389/frma.2021.644728 · Cited by 7
Effect of Combination Lipid-Modifying Therapy on the Triglyceride Lowering Effect of Fish Oil
Aligeti, V. R., Gandhi, M., Elam, M. B., Braden, R., & Rezk, A. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3180312ebf · Cited by 7
Omega-3 fatty acids and ventricular arrhythmias: Nothing is simple
Albert, C. M. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.02.001 · Cited by 7
High-Density Lipoprotein Cholesterol
Gotto, P. P. T. A. A. M. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-14 · Cited by 7
Fish Oil Supplementation and Arrhythmias
Strauss, M. H., Dorian, P., & Verma, S. (2005) · JAMA · doi:10.1001/jama.294.17.2165-a · Cited by 7
Toth, P. P., & Banach, M. (2025) · Archives of Medical Science · doi:10.5114/aoms/216960 · Cited by 7
Che, J., He, N., Kuang, X., Zheng, C., Zhou, R., Zhan, X., & Liu, Z. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae265 · Cited by 6
Wild-Type Land-Based Food in Health Promotion and Disease Prevention
Meester, F. D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-330-1_1 · Cited by 6
Fish, n-3 Polyunsaturated Fatty Acids, and Cardiovascular Disease
McEvoy, C. T., Young, I. S., & Woodside, J. V. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-894-8_10 · Cited by 7
Combined Phytosterol and Fish Oil Therapy for Lipid Lowering and Cardiovascular Health
Phang, M., & Garg, M. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404610-8.00016-5 · Cited by 6
Pharmacokinetics and Safety Profile of Omega-3 Polyunsaturated Fatty Acids
Tamargo, J. L., & Tamargo, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-40458-5_39 · Cited by 7
Hall, W. L. (2024) · Proceedings of The Nutrition Society · doi:10.1017/s0029665124000181 · Cited by 7
Athyros, V. G., Τζιόμαλος, Κ., & Karagiannis, A. I. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1072047 · Cited by 6
The Optimal Male Health Diet and Dietary Supplement Program
Moyad, M. A. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.006 · Cited by 6
Holdsworth, C. T., Copp, S. W., Hirai, D. M., Ferguson, S. K., Sims, G. E., Hageman, K. S., Stebbins, C. L., Poole, D. C., & Musch, T. I. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0301 · Cited by 6
New Data on the Clinical Impact of Exercise Training, Fish Oils, and Statins in Heart Failure
Lavie, C. J., O’Keefe, J. H., Milani, R. V., Ventura, H. O., & Mehra, M. R. (2009) · The Physician and Sportsmedicine · doi:10.3810/psm.2009.06.1706 · Cited by 7
Jenkins, N. D. M., Housh, T. J., Miramonti, A. A., McKay, B. D., Yeo, N. M., Smith, C. M., Hill, E. C., Cochrane, K. C., & Cramer, J. T. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.08.004 · Cited by 6
Abdissa, D. (2021) · Nutrition and Dietary Supplements · doi:10.2147/nds.s298870 · Cited by 6
Halcox, J. (2013) · Clinical Lipidology · doi:10.2217/clp.13.16 · Cited by 6
Mother was right about cod liver oil.
Griffing, G. T. (2008) · PubMed Central · Cited by 6
Vitamins for Cardiovascular Diseases
Sultan, S., Murarka, S., Jahangir, A., Mookadam, F., Tajik, A. J., & Jahangir, A. (2017) · Cardiology in Review · doi:10.1097/crd.0000000000000150 · Cited by 6
N-3 Fatty Acids from Fish and Plants: Primary and Secondary Prevention of Cardiovascular Disease
Connor, W. E., & Connor, S. L. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-542-2_10 · Cited by 5
Basu, H. N., Pernecky, S. J., Sengupta, A. M., & Liepa, G. U. (2006) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-006-5153-4 · Cited by 6
Tuleta, I., Bauriedel, G., Hasenbank, I., Andrié, R., Pabst, S., Nickenig, G., & Skowasch, D. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.04.014 · Cited by 6
Ware, W. R. (2010) · Cited by 6
Lipid-lowering therapies in development
Wierzbicki, A. S. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.11.1405 · Cited by 6
Kallergis, E. M., & Vardas, P. E. (2007) · PubMed · Cited by 6
Are n-3 Polyunsaturated Fatty Acids Antiarrhythmic in the Absence of Ischemia?
Raitt, M. H. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6151-6 · Cited by 6
Roy, J., Oger, C., Thireau, J., Pinot, E., Lee, J. C., Lacampagne, A., Galano, J., Durand, T., & Guennec, J. Y. L. (2015) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(15)30102-6 · Cited by 6
Adherence to dietary guidelines: benefits on atherosclerosis progression
Kris‐Etherton, P. M. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28074 · Cited by 6
Effects of n-3 polyunsaturated fatty acid on upper limit of vulnerability shocks
Chattipakorn, N., Shinlapawittayatorn, K., Sungnoon, R., & Chattipakorn, S. C. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.03.032 · Cited by 6
Metadata
- Authors
- Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., Mantini, L., Marfisi, R. M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G. L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., & Valagussa, F.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- From the Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti (R.M., F.B., E.B., R.D.M., R.M.M., G.T.); Ospedale Civile, Caserta (C.C.); Ospedale Civile, Lanciano (D.D.G., L.M., G.M., C.T.); Department of Cardiovascular Research, Istituto Mario Negri, Milano (M.G.F.); Ospedale Cervello, Palermo (E.G.); Ospedale Civile, Vasto (G.L.); Centro Studi ANMCO, Firenze (A.P.M.); Ospedale Civile, Napoli (N.M.); Ospedale S. Maria degli Angeli, Pordenone (G...
- Corresponding author
- Marchioli, Roberto
- Venue
- Circulation
- Published
- 2002-04-23
- Volume
- 105
- Issue
- 16
- Pages
- 1897-1903
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2128788220
- Cited by
- 1,311
- References
- 36
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 27 · 2023: 18 · 2022: 21 · 2021: 17 · 2020: 30 · 2019: 20 · 2018: 33 · 2017: 42 · 2016: 42 · 2015: 49 · 2014: 64 · 2013: 87 · 2012: 84
- FWCI
- 60.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Istituto di Ricerche Farmacologiche Mario Negri - IRCCS
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- omega-3 fatty acids, myocardial infarction, sudden death, mortality, vitamin E, antiarrhythmic effect, time course of treatment effects, cardiovascular mortality, coronary artery disease, cerebrovascular events
- MeSH terms
- Anti-Arrhythmia Agents, Female, Follow-Up Studies, Humans, Italy, Kinetics, Lipids, Male, Middle Aged, Myocardial Infarction, Fatty Acids, Omega-3, Death, Sudden, Cardiac, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
